INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 161 filers reported holding INTERSECT ENT INC in Q2 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,789,000 | +4.3% | 242,370 | +1.7% | 0.00% | 0.0% |
| Q4 2021 | $6,512,000 | +4.8% | 238,428 | +4.4% | 0.00% | 0.0% |
| Q3 2021 | $6,211,000 | +59.3% | 228,329 | +0.1% | 0.00% | +100.0% |
| Q2 2021 | $3,899,000 | -15.2% | 228,097 | +3.6% | 0.00% | -50.0% |
| Q1 2021 | $4,598,000 | -6.8% | 220,185 | +2.2% | 0.00% | 0.0% |
| Q4 2020 | $4,933,000 | +42.3% | 215,407 | +1.4% | 0.00% | 0.0% |
| Q3 2020 | $3,467,000 | +19.3% | 212,532 | -1.0% | 0.00% | +100.0% |
| Q2 2020 | $2,906,000 | +26.2% | 214,616 | +10.5% | 0.00% | 0.0% |
| Q1 2020 | $2,302,000 | -51.5% | 194,205 | +1.9% | 0.00% | -66.7% |
| Q4 2019 | $4,744,000 | +49.4% | 190,496 | +2.0% | 0.00% | +50.0% |
| Q3 2019 | $3,176,000 | -23.2% | 186,679 | +2.8% | 0.00% | -33.3% |
| Q2 2019 | $4,133,000 | -26.2% | 181,560 | +4.2% | 0.00% | -25.0% |
| Q1 2019 | $5,604,000 | +18.4% | 174,291 | +3.8% | 0.00% | 0.0% |
| Q4 2018 | $4,732,000 | -13.4% | 167,896 | -11.6% | 0.00% | 0.0% |
| Q3 2018 | $5,462,000 | -18.5% | 189,957 | +6.1% | 0.00% | -20.0% |
| Q2 2018 | $6,702,000 | +1.9% | 178,953 | +6.9% | 0.01% | 0.0% |
| Q1 2018 | $6,578,000 | +26.2% | 167,363 | +4.0% | 0.01% | +25.0% |
| Q4 2017 | $5,213,000 | +45.0% | 160,883 | +39.4% | 0.00% | +33.3% |
| Q3 2017 | $3,596,000 | +35.8% | 115,439 | +21.8% | 0.00% | +50.0% |
| Q2 2017 | $2,648,000 | +27.7% | 94,739 | -21.6% | 0.00% | 0.0% |
| Q1 2017 | $2,073,000 | +50.4% | 120,838 | +6.1% | 0.00% | 0.0% |
| Q4 2016 | $1,378,000 | -19.0% | 113,875 | +6.1% | 0.00% | 0.0% |
| Q3 2016 | $1,701,000 | +99.9% | 107,329 | +63.2% | 0.00% | +100.0% |
| Q2 2016 | $851,000 | -12.9% | 65,748 | +27.9% | 0.00% | 0.0% |
| Q1 2016 | $977,000 | -13.8% | 51,408 | +2.0% | 0.00% | -50.0% |
| Q4 2015 | $1,134,000 | -6.7% | 50,388 | -2.9% | 0.00% | 0.0% |
| Q3 2015 | $1,215,000 | +112.4% | 51,912 | +160.0% | 0.00% | +100.0% |
| Q2 2015 | $572,000 | +163.6% | 19,968 | +137.7% | 0.00% | – |
| Q1 2015 | $217,000 | – | 8,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |